Project Updates

Credit: Novo Nordisk

Location: Kalundborg, Denmark 
Project type: API Manufacturing Facility 
Area: 170,000m² 
Estimated Investment: More than DKr42bn ($6bn)

Novo Nordisk announced plans to expand its manufacturing capacity by building a new active pharmaceutical ingredients (API) facility in Kalundborg, Denmark. An investment of more than DKr42bn ($6bn) will be made in the project to enhance capacity throughout the entire global value chain.

Credit: Dreamsenses Photography

Location: Coralville, Iowa, US 
Project type: Therapeutic oligonucleotide manufacturing facility 
Area: 41,000ft² 
Opening date: October 2023

Integrated DNA Technologies (IDT) opened a therapeutic oligonucleotide manufacturing facility in Coralville, Iowa, US, in October 2023. IDT is a genomics solutions provider that is part of Danaher. The facility supplies good manufacturing practice (cGMP)-grade cell and gene therapy reagents.

Credit: Aragen Life Sciences Ltd

Location: Bangalore, India 
Project type: Biologics manufacturing facility 
Area: 160,000m² 
Estimated investment: $30m

Aragen Life Sciences will build its first biologics manufacturing facility in Bangalore, India. The facility will be utilised to develop and manufacture monoclonal antibodies, therapeutic proteins, and fusion proteins, enhancing the company’s existing bioproduction capability in California, US.